EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Evaluation of Novel Heterocyclic Derivatives of 2,4‐Thiazolidine Dione as Anti‐Cancer Agents

Kiran Kumar Vunnam, Naresh Kumar Katari, Nagalakshmi Jeedimalla, Rambabu Gundla, Jayaprakash Kanijam Raghupathi

Applied Research · 2025-02 · 4 (1)

DOI: 10.1002/appl.202400176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Research, online erschienen am 13.10.2024. Verfasst von Kiran Kumar Vunnam und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the development of novel 2,4‐thiazolidinedione derivatives as potential anticancer agents. We report the synthesis of 15 novel analogs utilizing a strategic approach focused on intermediate diversification. Key intermediates, (Z)‐5‐([1,1′‐biphenyl]‐4‐ylmethylene)thiazolidine‐2,4‐dione 5a and (Z)‐5‐(benzo[1,3]dioxol‐5‐ylmethylene)thiazolidine‐2,4‐dione 5b , were synthesized via Knoevenagel condensation and acetal formation reactions, respectively. Subsequent N‐alkylation reactions provided a platform for introducing diverse functionalities and exploring structure–activity relationships to optimize the medicinal chemistry profile of these novel compounds. The synthesized compounds were tested against various human cancer cell lines, including for breast (MCF‐7, MDA‐MB‐453), lung (A549), and prostate (PC‐3) cancers, using an MTT assay. Compounds 8c and 10g emerged as particularly promising, exhibiting activity against all tested cell lines with IC 50 values between 3.41 ± 0.51 and 40 μM. These compounds also induced apoptosis, suggesting that they inhibit cell proliferation through this cell death pathway. Moreover, relative molecular docking studies provided evidence that compound 8c likely functions by intercalating with DNA.

Zitieren

APA

Vunnam, K. K., Katari, N. K., Jeedimalla, N., Gundla, R., & Raghupathi, J. K. (2025). Design, Synthesis, and Biological Evaluation of Novel Heterocyclic Derivatives of 2,4‐Thiazolidine Dione as Anti‐Cancer Agents. Applied Research, 4(1). https://doi.org/10.1002/appl.202400176

Vancouver

Vunnam KK, Katari NK, Jeedimalla N, Gundla R, Raghupathi JK. Design, Synthesis, and Biological Evaluation of Novel Heterocyclic Derivatives of 2,4‐Thiazolidine Dione as Anti‐Cancer Agents. Applied Research. 2025;4(1). doi:10.1002/appl.202400176

BibTeX
@article{Vunnam2025,
  author = {Vunnam, Kiran Kumar and Katari, Naresh Kumar and Jeedimalla, Nagalakshmi and Gundla, Rambabu and Raghupathi, Jayaprakash Kanijam},
  title = {Design, Synthesis, and Biological Evaluation of Novel Heterocyclic Derivatives of 2,4‐Thiazolidine Dione as Anti‐Cancer Agents},
  journal = {Applied Research},
  year = {2025},
  volume = {4},
  number = {1},
  doi = {10.1002/appl.202400176}
}
Kostenlos starten →